Related Experiment Videos
Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human
T Yamada1, H Akiyama, P L McGeer
1University of British Columbia, Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Vancouver, Canada.
Neuroscience Letters
|May 4, 1990
Summary
Complement proteins C3d and C4d attach to oligodendroglia in various neurological disorders, including Alzheimer's and Parkinson's disease. This indicates complement pathway activation in affected brain tissue, rarely seen in healthy controls.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Oligodendroglia are crucial for myelin maintenance in the central nervous system.
- Dysfunction of oligodendroglia and myelin is implicated in numerous neurological disorders.
- The role of the complement system in these conditions is not fully understood.
Purpose of the Study:
- To investigate the presence and localization of complement proteins C3d and C4d in human brain tissue from patients with various neurological disorders.
- To determine if complement deposition is associated with oligodendroglia and myelin.
Main Methods:
- Immunohistochemistry was used to detect C3d and C4d in human brain tissue samples.
- Antibodies specific to C3d and C4d were employed.
- Immunogold electron microscopy was utilized for ultrastructural analysis.
Main Results:
- Clusters of oligodendroglial fibers expressing C3d and C4d were identified in multiple neurological diseases (Pick's, Huntington's, Parkinson's, Alzheimer's, ALS, PSP, Shy-Drager).
- These complement-activated oligodendroglia were found in specific gray and white matter regions.
- Rarely observed in control brain tissue.
- Electron microscopy confirmed C4d antibody binding to degenerating myelin sheaths.
Conclusions:
- The classical complement pathway is activated and its proteins attach to selective oligodendroglia in several human neurological disorders.
- Complement deposition on degenerating myelin suggests a role in myelin breakdown in these diseases.
- Findings highlight a potential link between complement system dysregulation and oligodendroglial pathology in neurodegeneration.